Related Experiment Video
Updated: May 2, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Institutional spillover effects of antimicrobial use on antimicrobial resistance and Clostridioides difficile: a
Sumit Raybardhan1, Bradley Langford2, Russell Forrest1
1University of Toronto Dalla Lana School of Public Health, Canada.
Objective:
To synthesize evidence on institutional spillover effects of antimicrobial use (AMU) on antimicrobial resistance (AMR) and Clostridioides difficile infections on individuals without direct antimicrobial exposure.
Design:
Systematic review.
Methods:
Three databases were searched through August 2024 for studies evaluating spillover effects of AMU on unexposed individuals in institutional settings. Study characteristics, AMU, and outcomes were extracted. Study quality was assessed based on underlying methodology to detect spillover effect. A hybrid synthesis, including effect direction and meta-analysis of studies reporting continuous AMU and non-aggregate outcomes was utilized. Reporting followed PRISMA guidelines.
Results:
Of 5916 screened studies, five observational studies met inclusion criteria. Three were conducted across 68 hospital wards (ward-level exposure), and two across 693 nursing homes (facility-level exposure). Three studies evaluated all antimicrobial classes; two focused on penicillins, fluoroquinolones, and carbapenems. Two studies examined C. difficile, one MRSA, one carbapenem-resistant Enterobacterales, and one reported combined AMR and C. difficile outcomes. Low to moderate quality evidence indicated a positive spillover effect direction with increasing facility AMU. Meta-analysis of three studies yielded a pooled IRR of 1.54 (95% CI 0.85-2.80) per 100 days of therapy per 1,000 patient-days, with significant heterogeneity (I 2 = 97.6%).
Conclusions:
This review identified five studies suggesting a positive association between institutional AMU and collateral risks of AMR and C. difficile among unexposed individuals. Findings were limited by methodological heterogeneity and potential publication bias. Standardizing terminology, specifying spillover mechanisms, and adopting robust observational designs can enhance future research on spillover effects.
Insights
Antimicrobial use in institutions may increase the risk of antimicrobial resistance (AMR) and Clostridioides difficile infections in unexposed individuals. This systematic review highlights collateral risks, emphasizing the need for further research.
Area of Science:
- Infectious Diseases
- Public Health
- Epidemiology
Background:
- Antimicrobial use (AMU) within healthcare settings can lead to the development of antimicrobial resistance (AMR) and infections like Clostridioides difficile.
- Understanding the indirect effects, or spillover effects, of AMU on unexposed individuals is crucial for infection control.
Purpose of the Study:
- To synthesize existing evidence on the institutional spillover effects of AMU on AMR and C. difficile infections in individuals not directly exposed to antimicrobials.
Main Methods:
- A systematic review was conducted, searching three databases through August 2024.
- Five observational studies were included, analyzing data from hospital wards and nursing homes.
- A hybrid synthesis approach, including meta-analysis, was used, adhering to PRISMA guidelines.
Main Results:
- Low to moderate quality evidence suggests a positive spillover effect: increased facility AMU is associated with higher collateral risks.
- Meta-analysis of three studies indicated a pooled IRR of 1.54 (95% CI 0.85-2.80) per 100 days of therapy per 1,000 patient-days, with significant heterogeneity.
Conclusions:
- Institutional AMU is associated with increased risks of AMR and C. difficile in unexposed individuals.
- Methodological limitations and potential bias necessitate further research with standardized terminology and robust designs to clarify spillover mechanisms.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Antimicrobial Effectiveness
Development of Antibiotic Resistance
Inhibitors of Bacterial DNA Synthesis
Antibiotic Selection

